Best GLP-1 Without Insurance 2026: Most Affordable Options Ranked
The most affordable GLP-1 options for uninsured patients ranked by total monthly cost in 2026. Compare Trimi, Ivim, Mochi, Sesame, Hims, Found, and brand-name cash-pay pricing side by side — including membership fees, what's included, and who each option is best for.
Written by Trimi Medical Team. Medically reviewed by Dr. Amanda Foster, MD. Rankings based on verified public pricing as of April 2026 — confirm current rates directly with each provider before enrolling.
Quick links: Semaglutide treatment, tirzepatide treatment, and GLP-1 providers for uninsured patients.
More on GLP-1 Cost & Access
Cheapest GLP-1 Providers Ranked
Most affordable compounded GLP-1 options ranked by total cost.
Semaglutide Without Insurance
How to afford semaglutide without coverage and strategies that work.
Tirzepatide Without Insurance
Complete guide to getting tirzepatide when you pay out of pocket.
GLP-1 Providers No Insurance
Every major telehealth GLP-1 platform reviewed for uninsured patients.
Why Uninsured Patients Need a Different Comparison
Most GLP-1 cost guides assume you have insurance. They discuss prior authorization, formulary tiers, and copay cards that do nothing for the tens of millions of Americans who pay out of pocket. For uninsured patients, the math is entirely different — and the winner is not necessarily the most advertised brand.
Brand-name semaglutide (Wegovy) and tirzepatide (Zepbound) run $1,000–$1,500 per month at cash-pay retail prices. That makes a full year of brand-name treatment cost more than many Americans earn in six months. Compounded versions of the same active ingredients — available through licensed telehealth platforms — have made GLP-1 therapy accessible to millions of patients who would otherwise be completely priced out.
But even among compounded options, pricing varies widely — and the advertised price is not always the real price. This ranking cuts through the noise by calculating total effective monthly cost for an uninsured patient: medication plus any membership or platform fee, all in.
GLP-1 Without Insurance: Providers Ranked by Total Cost
Rankings use total effective monthly cost — medication price plus any required membership or platform fee — for a standard maintenance dose of semaglutide. Tirzepatide pricing is noted separately where available.
| Rank | Provider | Semaglutide (all-in) | Tirzepatide (all-in) | Membership Fee | Annual (sema) |
|---|---|---|---|---|---|
| 1 | TrimiBest Value | $99/mo | $125/mo | None | ~$1,188 |
| 2 | Ivim Health | ~$150–175/mo* | Higher | $75/mo | ~$1,800–2,100 |
| 3 | Mochi | ~$178/mo* | Higher | $79/mo | ~$2,136 |
| 4 | Sesame | ~$59/mo sub + Rx cost | Varies | $59/mo sub | Varies |
| 5 | Hims | ~$199/mo | Not offered | None listed | ~$2,388 |
| 6 | Found | $129–299/mo | Varies | Included | $1,548–3,588 |
| 7 | Brand-name cash pay | $1,000–1,350/mo | $550–1,059/mo† | None | $12,000–16,200 |
* Ivim: $75–100/mo medication + $75/mo membership. Mochi: $99/mo medication + $79/mo membership. Verify current rates with each provider.
† Zepbound single-dose vials cash price via LillyDirect. Brand-name brand-pay terms change; verify directly before comparing.
Provider-by-Provider Breakdown
Trimi — $99/mo semaglutide, $125/mo tirzepatide
Trimi ranks first because it offers the lowest all-in monthly cost with no separate membership fee. Uninsured patients pay a flat $99/mo for compounded semaglutide or $125/mo for compounded tirzepatide — that price covers the medication, clinical consultation, ongoing provider access, injection supplies, and shipping. Nothing else to add.
What's included
- Compounded semaglutide or tirzepatide
- Provider consultation + ongoing access
- Injection supplies (syringes, swabs)
- Free shipping to your door
- Dose adjustment support
- No membership fee ever
Cost summary
- Semaglutide: $99/mo — $1,188/yr
- Tirzepatide: $125/mo — $1,500/yr
- Membership: $0
- Contract: None, cancel anytime
- Hidden fees: None
Best for: Uninsured patients who want the lowest reliable all-in price, no surprises, and a specialized GLP-1 program rather than a general telehealth platform. Learn more about how Trimi works and how Trimi compares to other providers.
Ivim Health — $75–100/mo + $75/mo membership
Ivim Health is a well-reviewed telehealth platform with 25,000+ five-star Trustpilot ratings and a holistic, integrative coaching model. The catch for uninsured patients is the two-part pricing: medication is $75–$100/mo, but that does not include the $75/mo membership fee. A typical Ivim patient spending $85/mo on medication plus $75 membership pays $160/mo — or $1,920/yr for semaglutide. That's $732 more per year than Trimi's flat rate.
Strengths
- 25,000+ verified Trustpilot reviews
- Holistic coaching + lifestyle guidance
- Integrative approach with GLP-1 Rx
- Strong patient satisfaction scores
- Both semaglutide and tirzepatide
Cost considerations
- Medication: $75–100/mo
- Membership: +$75/mo
- All-in (typical): ~$150–175/mo
- Annual: ~$1,800–2,100
Best for: Patients who want a structured holistic program with behavioral coaching as a central feature and are comfortable paying a premium for that support. Read the full Ivim Health vs Trimi comparison and Ivim Health cost breakdown.
Mochi Health — $99/mo + $79/mo membership
Mochi Health focuses on board-certified obesity medicine specialists and comprehensive metabolic care. Like Ivim, their pricing is split: $99/mo for the medication plus a $79/mo membership for the full program. Total all-in cost is approximately $178/mo — or $2,136/yr for semaglutide — which is notably higher than Trimi's flat rate despite a similar advertised medication price.
Strengths
- Obesity medicine specialists
- Comprehensive metabolic evaluation
- Nutrition and behavior coaching
- Insurance navigation assistance
- Detailed health monitoring
Cost considerations
- Medication: $99/mo
- Membership: +$79/mo
- All-in: ~$178/mo
- Annual: ~$2,136
Best for: Patients who want obesity medicine specialist oversight and comprehensive metabolic care and are willing to pay a premium for that clinical depth.
Sesame — $59/mo subscription + medication cost
Sesame operates as a healthcare marketplace that connects patients to independent providers at discounted rates. A $59/mo Sesame Plus subscription unlocks lower consultation prices, and you then pay separately for the prescription and medication from a pharmacy of your choice. The total cost depends heavily on your medication source — compounded semaglutide from a third-party pharmacy can bring total costs competitive with other platforms, but it requires more coordination and comparison shopping on your part.
Best for: Patients who already have a trusted compounding pharmacy or want flexibility in choosing their medication source, and are comfortable managing the consultation and dispensing steps separately.
Hims — ~$199/mo
Hims offers a well-known consumer brand and a large general telehealth platform. Their GLP-1 program runs approximately $199/mo for compounded semaglutide — roughly double Trimi's $99/mo rate. Hims does not appear to offer compounded tirzepatide through their standard weight loss program. The $100/mo premium over Trimi translates to $1,200 per year in additional cost without a clear clinical advantage for most uninsured patients.
Best for: Patients who prefer a large, recognizable consumer brand and are already Hims customers for other services — the platform integration may add convenience worth the premium to some.
Found — $129–299/mo
Found combines GLP-1 medication management with behavioral health coaching and a proprietary app. Pricing ranges from $129/mo to $299/mo depending on the plan tier, which includes clinical support, coaching, and medication. The wide price range reflects meaningful differences in what is included at each level. At the lower end, Found is moderately competitive; at the higher end, it is significantly more expensive than Trimi for similar medication outcomes.
Best for: Patients who want behavioral health support integrated directly into their weight loss program and are willing to pay for that additional layer of accountability.
Brand-Name Cash Pay — $1,000–1,500/mo
Brand-name Wegovy (semaglutide) and Zepbound (tirzepatide) at full cash-pay retail prices run $1,000–$1,350/mo and $550–$1,059/mo respectively. These are the same active ingredients available through compounded telehealth platforms at $99–$199/mo. For uninsured patients, brand-name cash pay is almost never the right choice unless manufacturer assistance programs apply. Zepbound's single-dose vials, available via LillyDirect, represent the most competitive brand-name cash price for tirzepatide — still well above compounded rates.
Best for: Patients who qualify for manufacturer patient assistance programs (PAP) or who have specific clinical reasons to prefer brand-name over compounded — such as needing the auto-injector pen device rather than vial-and-syringe delivery. Learn about appealing insurance denials before defaulting to full cash-pay brand pricing.
What to Look For When Comparing GLP-1 Providers Without Insurance
Price is the most important factor for uninsured patients — but it is not the only one. These are the questions to ask before enrolling in any GLP-1 program:
What is the all-in monthly price? Add medication cost plus any membership, platform, or subscription fee.
Is there a membership fee? If so, what does it include that justifies the additional charge?
What pharmacy dispenses the medication? Look for PCAB-accredited or FDA-registered 503B facilities.
Who prescribes the medication? Confirm a licensed provider evaluates your health before prescribing.
What ongoing support is included? Dose adjustments, side effect management, and clinical check-ins matter.
Are supplies included? Syringes, needles, and alcohol swabs should ideally be included at no extra cost.
Is there a contract? Month-to-month flexibility protects you if your needs or circumstances change.
How are dose escalations priced? Some programs increase cost as dose increases — understand this upfront.
See the complete guide to buying semaglutide without insurance and the complete guide to buying tirzepatide without insurance for deeper evaluation frameworks.
Red Flags to Avoid
Warning signs when seeking affordable GLP-1 medication
No prescription required — legitimate GLP-1 medications always require a valid prescription from a licensed provider.
No identified pharmacy — providers should be able to name the compounding facility they use and explain its quality standards.
Prices dramatically below market (e.g., $20–30/mo for compounded semaglutide) without explanation — quality compounding has real costs.
Social media sellers, group buys, or research chemical suppliers — these are not legitimate pharmaceutical channels.
International pharmacies with no verifiable regulatory oversight — importation rules are complex and enforcement is real.
No medical questionnaire or health screening — prescribing GLP-1s without evaluating your health history is a red flag.
Promises of 'generic Ozempic' or 'FDA-approved generic semaglutide' — no such generic exists as of April 2026.
Cutting Costs Further: HSA, FSA, and Manufacturer Programs
HSA and FSA: Tax-Advantaged Payment
If you have a Health Savings Account (HSA) or Flexible Spending Account (FSA) through your employer, you can use those pre-tax dollars to pay for GLP-1 medications prescribed for a qualifying medical purpose. Most telehealth platforms including Trimi accept HSA and FSA cards directly.
How HSA/FSA savings work on a $99/mo Trimi plan
22%
Tax bracket
$77/mo effective
24%
Tax bracket
$75/mo effective
32%
Tax bracket
$67/mo effective
Effective monthly cost calculated as $99 × (1 − marginal tax rate). Consult a tax advisor for your specific situation.
Manufacturer Patient Assistance Programs
For patients who specifically want brand-name medication and meet income requirements, manufacturer assistance programs can provide free or significantly reduced-cost access. These are worth pursuing before paying full cash-pay rates.
Novo Nordisk PAP (Wegovy, Ozempic)
- • Income ≤ 400% federal poverty level
- • No prescription drug coverage for medication
- • U.S. resident with valid prescription
- • Phone: 1-866-310-7549
- • Web: pap.novonordisk-us.com
- • Processing: 2–4 weeks
Lilly Cares (Zepbound, Mounjaro)
- • Income ≤ 400% federal poverty level
- • No coverage for the specific medication
- • U.S. resident with valid prescription
- • Phone: 1-800-545-6962
- • Web: lillycares.com
- • Processing: 2–4 weeks
Also review how to appeal insurance denials — some patients who believe they are uninsured for GLP-1 coverage may have viable appeal pathways through their plan.
Bottom Line: Which Provider Should Uninsured Patients Choose?
For most uninsured patients focused on keeping costs low, Trimi is the clear top choice. At $99/mo all-inclusive for semaglutide and $125/mo for tirzepatide — with no membership fee, no contract, and no hidden costs — Trimi offers the lowest verified total cost among established telehealth platforms we reviewed.
The decision changes if you specifically want a structured coaching program (Mochi or Ivim may justify the higher price for some patients), need insurance navigation support, or qualify for a manufacturer PAP for brand-name access.
Quick decision guide for uninsured patients
- Lowest all-in price, no membership: Trimi ($99/mo semaglutide, $125/mo tirzepatide)
- Holistic coaching focus, willing to pay more: Ivim Health (~$150–175/mo)
- Obesity medicine specialist oversight: Mochi (~$178/mo)
- Already have compounding pharmacy, want to minimize consultation cost: Sesame ($59/mo sub + Rx)
- Large consumer brand preference: Hims (~$199/mo)
- Meet income requirements for free brand-name medication: Manufacturer PAP
Frequently Asked Questions
What is the cheapest way to get semaglutide without insurance in 2026?
The cheapest all-inclusive option for uninsured patients in 2026 is Trimi at $99 per month for compounded semaglutide with no membership fee. That price covers the medication, clinical consultation, ongoing provider access, and supplies shipped to your door. For comparison, Ivim Health charges $75–$100/mo for medication plus a $75 monthly membership, Mochi charges $99/mo plus a $79 membership, and brand-name Wegovy can run $1,000–$1,350/mo cash pay without any savings program. Compounded semaglutide through a legitimate telehealth provider is the lowest total-cost route for most uninsured patients.
Is compounded semaglutide safe for patients without insurance?
Yes, when sourced from a properly licensed compounding pharmacy. Compounded semaglutide contains the same active ingredient as brand-name Wegovy or Ozempic. Safety depends on the quality of the pharmacy and the clinical oversight provided — not on your insurance status. Look for providers that partner with PCAB-accredited or FDA-registered 503B outsourcing facilities, conduct third-party potency and sterility testing, and require a valid prescription from a licensed provider. Trimi, Ivim, Mochi, and other established telehealth platforms meet these criteria.
What should I watch out for when comparing GLP-1 prices without insurance?
The most common trap is comparing a low medication price without accounting for a separate monthly membership fee. Ivim Health's advertised $75–$100/mo price requires adding a $75 membership. Mochi's $99/mo medication price requires adding a $79 membership. When you add those up, the real monthly cost is $150–$175+ for Ivim and $178+ for Mochi — higher than Trimi's flat $99 all-inclusive. Always ask: what does the monthly price actually include, and are there any additional fees beyond the medication cost?
Can I use HSA or FSA funds to pay for GLP-1 medications without insurance?
Yes. Health Savings Account (HSA) and Flexible Spending Account (FSA) funds can be used to pay for GLP-1 medications prescribed for a qualifying medical purpose — including obesity. This applies to compounded semaglutide and tirzepatide when prescribed by a licensed provider. Paying with pre-tax HSA or FSA dollars effectively reduces your after-tax cost by 20–35% depending on your tax bracket. For example, a Trimi patient in the 22% bracket paying $99/mo with HSA funds effectively pays about $77/mo in pre-tax dollars.
Are there manufacturer programs for uninsured patients who want brand-name GLP-1?
Yes. Novo Nordisk (Wegovy, Ozempic) and Eli Lilly (Zepbound) each offer patient assistance programs for uninsured patients who meet income requirements — typically at or below 400% of the federal poverty level (approximately $58,000 for an individual in 2026). These programs can provide free or significantly reduced-cost brand-name medication. Contact Novo Nordisk at 1-866-310-7549 or visit pap.novonordisk-us.com, and Lilly Cares at 1-800-545-6962 or lillycares.com. Processing typically takes 2–4 weeks and requires income documentation.
What is the difference between Hims and Trimi for semaglutide without insurance?
Hims offers compounded semaglutide at approximately $199/mo, which is roughly double Trimi's $99/mo all-inclusive price. Both platforms include clinical consultation and medication delivery. Hims has broader brand recognition and a large general telehealth platform, while Trimi is a specialized GLP-1 weight loss program. For uninsured patients focused on keeping costs low, the $100/mo difference amounts to $1,200 per year — significant over any meaningful treatment duration. Trimi's specialized focus also means providers have deeper expertise in GLP-1 titration and side effect management.
How do I get started with a GLP-1 program without insurance?
The process is the same regardless of insurance status. Complete an online health assessment on the platform of your choosing — this typically covers your medical history, current medications, BMI, and weight loss goals. A licensed provider reviews your information (usually within 24 hours) and issues a prescription if you are a clinical candidate. Your medication is prepared by the platform's compounding pharmacy and shipped directly to you, typically within 5–7 days of approval. No prior authorization, no insurance forms, and no coverage denials. Most platforms accept HSA/FSA cards alongside standard credit and debit cards.
Sources & References
- Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387:205-216.
- FDA guidance on drug compounding regulations and FAQ.
- FDA drug shortage database — semaglutide and tirzepatide status.
- NABP compounding pharmacy accreditation standards (PCAB).
- NIDDK overview of prescription weight loss medications.
- IRS Publication 969: Health Savings Accounts and other tax-favored health plans.
- Wegovy (semaglutide) prescribing information, FDA.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Pricing data is based on publicly available information as of April 2026 and is subject to change — verify current rates directly with each provider before enrolling. Trimi is one of the providers ranked in this article. Always consult a qualified healthcare provider before starting any medication or treatment program.